Micromet Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 240

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.15B

Micromet General Information

Description

Developer of proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. The company offers antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies.

Contact Information

Formerly Known As
Cancervax, Cancervax Corp
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6707 Democracy Boulevard
  • Suite 505
  • Bethesda, MD 20817
  • United States
+1 (240)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 6707 Democracy Boulevard
  • Suite 505
  • Bethesda, MD 20817
  • United States
+1 (240)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micromet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 07-Mar-2012 $1.15B Completed Generating Revenue
7. 2PO 17-Mar-2010 Completed Generating Revenue
6. 2PO 04-Aug-2009 Completed Generating Revenue
5. PIPE 02-Dec-2008 Completed Generating Revenue
4. PIPE 02-Oct-2008 Completed Generating Revenue
3. Secondary Transaction - Open Market 16-Dec-2004 Completed Clinical Trials - Phase 3
2. IPO 30-Oct-2003 $72M $67M Completed Clinical Trials - Phase 3
1. Early Stage VC Completed Startup
To view Micromet’s complete valuation and funding history, request access »

Micromet Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Micromet Former Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Advent Life Sciences Venture Capital Minority
Advent Venture Partners Venture Capital Minority
Athenian Venture Partners Venture Capital Minority
Atlas Venture Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

Micromet FAQs

  • When was Micromet founded?

    Micromet was founded in 1993.

  • Where is Micromet headquartered?

    Micromet is headquartered in Bethesda, MD.

  • What is the size of Micromet?

    Micromet has 240 total employees.

  • What industry is Micromet in?

    Micromet’s primary industry is Drug Discovery.

  • Is Micromet a private or public company?

    Micromet is a Private company.

  • What is the current valuation of Micromet?

    The current valuation of Micromet is .

  • What is Micromet’s current revenue?

    The current revenue for Micromet is .

  • How much funding has Micromet raised over time?

    Micromet has raised $313M.

  • Who are Micromet’s investors?

    Abingworth, Advent Life Sciences, Advent Venture Partners, Athenian Venture Partners, and Atlas Venture are 5 of 24 investors who have invested in Micromet.

  • When was Micromet acquired?

    Micromet was acquired on 07-Mar-2012.

  • Who acquired Micromet?

    Micromet was acquired by Amgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process